-transparent.png){kind=logo}
Leucocyte sodium efflux was measured in control leucocytes pre-incubated for 90 min with serum from patients with advanced liver cirrhosis. Serum from patients with advanced alcoholic liver cirrhosis was inhibitory to sodium transport in control leucocytes. The degree of inhibition was similar to that seen in the patients' own leucocytes; the defect induced by patient serum was primarily inhibition of ouabain-insensitive sodium efflux, whereas in the patients' own leucocytes, inhibition was seen in both ouabain-sensitive and -insensitive sodium efflux, as shown previously. The results suggest that a circulating factor, present in patients with advanced cirrhosis, is capable of inhibiting sodium transport in leucocytes.
R B Sewell, and
L Poston, and
S P Wilkinson, and
R Williams
October 1984,
British medical journal (Clinical research ed.),
R B Sewell, and
L Poston, and
S P Wilkinson, and
R Williams
January 1985,
British medical journal (Clinical research ed.),
R B Sewell, and
L Poston, and
S P Wilkinson, and
R Williams
January 1984,
Journal of cardiovascular pharmacology,
R B Sewell, and
L Poston, and
S P Wilkinson, and
R Williams
January 1980,
Scandinavian journal of gastroenterology,
R B Sewell, and
L Poston, and
S P Wilkinson, and
R Williams
April 1981,
British medical journal (Clinical research ed.),
R B Sewell, and
L Poston, and
S P Wilkinson, and
R Williams
September 1975,
Clinical science and molecular medicine,
R B Sewell, and
L Poston, and
S P Wilkinson, and
R Williams
April 1987,
Clinical endocrinology,
R B Sewell, and
L Poston, and
S P Wilkinson, and
R Williams
January 1957,
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
R B Sewell, and
L Poston, and
S P Wilkinson, and
R Williams
September 1987,
Clinical science (London, England : 1979),
R B Sewell, and
L Poston, and
S P Wilkinson, and
R Williams
September 2016,
Clinical physiology and functional imaging,
